ATE243198T1 - Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen - Google Patents
Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenenInfo
- Publication number
- ATE243198T1 ATE243198T1 AT98901776T AT98901776T ATE243198T1 AT E243198 T1 ATE243198 T1 AT E243198T1 AT 98901776 T AT98901776 T AT 98901776T AT 98901776 T AT98901776 T AT 98901776T AT E243198 T1 ATE243198 T1 AT E243198T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- pathogens
- methods
- claveable
- inactivation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 244000052769 pathogen Species 0.000 title abstract 3
- 230000002779 inactivation Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 230000000415 inactivating effect Effects 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 239000012620 biological material Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/64—Acridine or hydrogenated acridine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77988597A | 1997-01-06 | 1997-01-06 | |
| US77983097A | 1997-01-07 | 1997-01-07 | |
| US4369697P | 1997-04-15 | 1997-04-15 | |
| PCT/US1998/000532 WO1998030545A1 (en) | 1997-01-06 | 1998-01-06 | Frangible compounds for pathogen inactivation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE243198T1 true ATE243198T1 (de) | 2003-07-15 |
Family
ID=27366374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98901776T ATE243198T1 (de) | 1997-01-06 | 1998-01-06 | Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1021414B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4551502B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101676268B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE243198T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU744089C (cg-RX-API-DMAC7.html) |
| CA (1) | CA2276532C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69815703T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2196530T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998030545A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101676268B (zh) * | 1997-01-06 | 2013-09-25 | 塞鲁斯公司 | 用于病原体灭活的脆性化合物 |
| ES2224415T3 (es) * | 1998-01-06 | 2005-03-01 | Cerus Corporation | Metodos para inhibir desactivadores patogenos en materiales biologicos. |
| WO1999063981A2 (en) * | 1998-06-11 | 1999-12-16 | Cerus Corporation | Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
| US7498156B2 (en) | 1998-07-21 | 2009-03-03 | Caridianbct Biotechnologies, Llc | Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components |
| US7049110B2 (en) | 1998-07-21 | 2006-05-23 | Gambro, Inc. | Inactivation of West Nile virus and malaria using photosensitizers |
| US6403359B1 (en) | 1998-09-25 | 2002-06-11 | V. I. TECHNOLOGIES, Inc. | Solid phase quenching systems |
| US6150109A (en) | 1999-01-25 | 2000-11-21 | V. I. TECHNOLOGIES, Inc. | Lipophilic quenching of viral inactivating agents |
| US7094378B1 (en) | 2000-06-15 | 2006-08-22 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
| US7220747B2 (en) | 1999-07-20 | 2007-05-22 | Gambro, Inc. | Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
| JP2003534383A (ja) * | 2000-05-31 | 2003-11-18 | セラス コーポレイション | 免疫原性が減少した赤血球の病原体不活性化溶液の調製 |
| US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
| DE10051628B4 (de) * | 2000-10-18 | 2007-06-06 | Fresenius Hemocare Beteiligungs Gmbh | Einzelsträngiges Oligonukleotid und dessen Verwendung |
| EP1365750A2 (en) * | 2000-12-21 | 2003-12-03 | Cerus Corporation | Methods for inactivation of pathogens in biological materials |
| AU2004224425B2 (en) * | 2003-02-06 | 2010-06-24 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
| KR101192652B1 (ko) | 2003-02-06 | 2012-10-19 | 앤저 테라퓨틱스 인코퍼레이티드 | 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법 |
| US7695725B2 (en) | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| AU2005302256B2 (en) | 2004-10-29 | 2011-01-20 | Cerus Corporation | Improved quenching methods for red blood cell inactivation process |
| CA2720824C (en) | 2008-04-09 | 2021-09-14 | Cerus Corporation | Improved quenching methods for red blood cell pathogen inactivation |
| HK1217092A1 (zh) | 2013-02-15 | 2016-12-23 | Kala Pharmaceuticals, Inc. | 治疗性化合物及其用途 |
| US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
| ES2831625T3 (es) | 2013-02-20 | 2021-06-09 | Kala Pharmaceuticals Inc | Compuestos terapéuticos y sus usos |
| KR20160099084A (ko) | 2013-11-01 | 2016-08-19 | 칼라 파마슈티컬스, 인크. | 치료 화합물의 결정질 형태 및 그의 용도 |
| US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| CN104788373A (zh) * | 2015-05-06 | 2015-07-22 | 武汉大学 | 化合物s-303盐酸盐的合成方法 |
| IL256381B2 (en) | 2015-06-26 | 2024-12-01 | Cerus Corp | Cryoprecipitate preparations and methods for their preparation |
| CN104991033A (zh) * | 2015-08-05 | 2015-10-21 | 上海海虹实业(集团)巢湖今辰药业有限公司 | 一种采用一测多评法测定川芎挥发油成分的方法 |
| CA3003097A1 (en) | 2015-10-23 | 2017-04-27 | Cerus Corporation | Plasma compositions and methods of use thereof |
| KR20190051010A (ko) | 2016-09-08 | 2019-05-14 | 칼라 파마슈티컬스, 인크. | 치료 화합물의 결정형 및 그의 용도 |
| US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| US10392399B2 (en) | 2016-09-08 | 2019-08-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| WO2018119462A1 (en) * | 2016-12-23 | 2018-06-28 | Cerus Corporation | Systems and methods for testing and screening using compound bound substrates |
| MX390725B (es) | 2017-03-03 | 2025-03-21 | Cerus Corp | Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado. |
| CA3087253A1 (en) | 2017-12-29 | 2019-07-04 | Cerus Corporation | Systems and methods for treating biological fluids |
| CN114173842A (zh) | 2019-06-22 | 2022-03-11 | 塞鲁斯公司 | 生物流体处理系统 |
| EP3991179A1 (en) | 2019-06-28 | 2022-05-04 | Cerus Corporation | System and methods for implementing a biological fluid treatment device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994020090A1 (en) * | 1993-03-17 | 1994-09-15 | Steritech, Inc. | Decontaminating clinical samples |
| US5691132A (en) * | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
| DE4444045C2 (de) * | 1994-12-10 | 1997-04-17 | Behringwerke Ag | Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten |
| WO1996039818A1 (en) * | 1995-06-07 | 1996-12-19 | Cerus Corporation | Treating red blood cell solutions with anti-viral agents |
| CN101676268B (zh) * | 1997-01-06 | 2013-09-25 | 塞鲁斯公司 | 用于病原体灭活的脆性化合物 |
-
1998
- 1998-01-06 CN CN2009101633119A patent/CN101676268B/zh not_active Expired - Lifetime
- 1998-01-06 DE DE69815703T patent/DE69815703T2/de not_active Expired - Lifetime
- 1998-01-06 WO PCT/US1998/000532 patent/WO1998030545A1/en not_active Ceased
- 1998-01-06 CA CA002276532A patent/CA2276532C/en not_active Expired - Fee Related
- 1998-01-06 AT AT98901776T patent/ATE243198T1/de not_active IP Right Cessation
- 1998-01-06 JP JP53119998A patent/JP4551502B2/ja not_active Expired - Lifetime
- 1998-01-06 ES ES98901776T patent/ES2196530T3/es not_active Expired - Lifetime
- 1998-01-06 CN CN988027348A patent/CN1248245B/zh not_active Expired - Lifetime
- 1998-01-06 AU AU58217/98A patent/AU744089C/en not_active Expired
- 1998-01-06 EP EP98901776A patent/EP1021414B1/en not_active Expired - Lifetime
-
2009
- 2009-12-17 JP JP2009286996A patent/JP5244083B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2276532A1 (en) | 1998-07-16 |
| JP5244083B2 (ja) | 2013-07-24 |
| DE69815703T2 (de) | 2004-06-03 |
| WO1998030545A1 (en) | 1998-07-16 |
| CN101676268B (zh) | 2013-09-25 |
| EP1021414A1 (en) | 2000-07-26 |
| DE69815703D1 (de) | 2003-07-24 |
| AU744089C (en) | 2003-07-31 |
| CN1248245A (zh) | 2000-03-22 |
| JP4551502B2 (ja) | 2010-09-29 |
| JP2010095527A (ja) | 2010-04-30 |
| EP1021414B1 (en) | 2003-06-18 |
| CA2276532C (en) | 2008-06-17 |
| HK1026702A1 (en) | 2000-12-22 |
| JP2001508449A (ja) | 2001-06-26 |
| HK1188441A1 (en) | 2014-05-02 |
| CN101676268A (zh) | 2010-03-24 |
| AU744089B2 (en) | 2002-02-14 |
| ES2196530T3 (es) | 2003-12-16 |
| CN1248245B (zh) | 2012-07-04 |
| AU5821798A (en) | 1998-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE243198T1 (de) | Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen | |
| ATE287210T1 (de) | Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen | |
| DE69328685D1 (de) | Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen | |
| DE69328777D1 (de) | Dekontaminierung von Plättchen mit 8-Methoxypsoralen | |
| IL197686A0 (en) | Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith | |
| AU9058091A (en) | Preparation of nucleic acid samples | |
| DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| ATE332142T1 (de) | Zusammensetzungen zur behandlung von tierischen krankheiten und syndromen mit transferfaktor | |
| RU94046367A (ru) | Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела | |
| AU2002248384A1 (en) | Serpin drugs for treatment of hiv infection and method of use thereof | |
| DE602004018788D1 (de) | Faktor-ixa-spezifische antikörper, die faktor-viiia-ähnliche wirkung zeigen | |
| DE69434445D1 (de) | Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt | |
| ES2168361T3 (es) | Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo. | |
| PT84089A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
| DE69725882D1 (de) | Adenovirus e4 proteine für induktion von zelltod | |
| EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
| ATE495193T1 (de) | Bag3-antikörper zur nutzung in forschung, diagnose und der behandlung von krankheiten, an denen zelltod beteiligt ist | |
| Blajchman | Protecting the blood supply from emerging pathogens: the role of pathogen inactivation | |
| ATE460947T1 (de) | Verfahren zur sterilisation von biologischen präparaten | |
| CN101757616A (zh) | 一种安全的冻干哺乳动物源凝血酶制剂及其制备方法 | |
| ATE237616T1 (de) | Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv | |
| DE59405845D1 (de) | Verwendung von 2-Methylamino-2-phenylcyclohexanon zur Behandlung von Infektionen und zur Immunmodulation | |
| UA10281C2 (uk) | Спосіб отримання речовини для лікування захворювань підшлункової залози | |
| DE50103679D1 (de) | Biokompatible kolloide mit geringer zelladhäsion und aktiver stabilisierung von blutproteinen | |
| UA23145A (uk) | Спосіб визhачеhhя активhості бромелаїhу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |